These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2696161)

  • 1. Asexual blood stage vaccines: from merozoites to peptides.
    Perrin LH; Simitsek P; Fasani-Ghersa P
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():53-6. PubMed ID: 2696161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines against asexual stage malaria parasites.
    Kumar S; Epstein JE; Richie TL
    Chem Immunol; 2002; 80():262-86. PubMed ID: 12058644
    [No Abstract]   [Full Text] [Related]  

  • 3. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic peptide vaccine confers protection against murine malaria.
    Zavala F; Tam JP; Barr PJ; Romero PJ; Ley V; Nussenzweig RS; Nussenzweig V
    J Exp Med; 1987 Nov; 166(5):1591-6. PubMed ID: 3316473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a malaria vaccine: what is in sight?
    del Giudice G
    Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant proteins and synthetic peptides as malaria vaccine candidates.
    Nussenzweig RS
    Can J Microbiol; 1990 Nov; 36(11):817-20. PubMed ID: 2279239
    [No Abstract]   [Full Text] [Related]  

  • 7. The main obstacle to a malaria vaccine: the malaria parasite.
    Miller LH; Good MF
    Vaccine; 1988 Apr; 6(2):104-6. PubMed ID: 3291447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B
    Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of synthetic and recombinant peptides in the study of host-parasite interactions in the malarias.
    Campbell GH; Aley SB; Ballou WR; Hall T; Hockmeyer WT; Hoffman SL; Hollingdale MR; Howard RJ; Lyon JA; Nardin EH
    Am J Trop Med Hyg; 1987 Nov; 37(3):428-44. PubMed ID: 2446515
    [No Abstract]   [Full Text] [Related]  

  • 10. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.
    Patarroyo ME; Amador R; Clavijo P; Moreno A; Guzman F; Romero P; Tascon R; Franco A; Murillo LA; Ponton G
    Nature; 1988 Mar; 332(6160):158-61. PubMed ID: 2450281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective antigens of bloodstage Plasmodium knowlesi parasites.
    Deans JA
    Philos Trans R Soc Lond B Biol Sci; 1984 Nov; 307(1131):159-69. PubMed ID: 6151680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of malaria vaccines that block transmission of parasites by mosquito vectors.
    Hisaeda H; Yasutomo K
    J Med Invest; 2002 Aug; 49(3-4):118-23. PubMed ID: 12323000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
    Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A
    Malar J; 2007 Aug; 6():107. PubMed ID: 17686163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential vaccine antigens of the asexual blood-stages of Plasmodium falciparum.
    Anders RF; Brown GV; Coppel RL; Stahl HD; Bianco AE; Favaloro JM; Crewther PE; Culvenor JG; Kemp DJ
    Dev Biol Stand; 1985; 62():81-9. PubMed ID: 2422079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biotechnological approaches to the creation of antimalarial vaccines].
    Lalaiants IE; Milovanova LS
    Med Parazitol (Mosk); 1990; (1):53-7. PubMed ID: 2191204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in the development of malaria vaccines: memorandum from a WHO meeting.
    Bull World Health Organ; 1984; 62(5):715-27. PubMed ID: 6391715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with synthetic peptides of a Plasmodium falciparum surface antigen induces antimerozoite antibodies.
    Cheung A; Leban J; Shaw AR; Merkli B; Stocker J; Chizzolini C; Sander C; Perrin LH
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8328-32. PubMed ID: 3534885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Achievements and problems in the development of malaria vaccines].
    Martínez-Gómez F
    Rev Latinoam Microbiol; 1993; 35(3):319-25. PubMed ID: 8047736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed allele malaria vaccines: host protection and within-host selection.
    Barclay VC; Chan BH; Anders RF; Read AF
    Vaccine; 2008 Nov; 26(48):6099-107. PubMed ID: 18804509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple antigen peptides (MAPs) as candidate vaccines against malaria.
    Pessi A; Bianchi E; Chiappinelli L; Bonelli F; Tougne C; Lambert PH; Del Giudice G
    Parassitologia; 1991 Apr; 33(1):79-84. PubMed ID: 1668679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.